- $4.00m
- $6.02m
- $5.43m
Annual balance sheet for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.029 | 0.028 | 0.054 | 0.458 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.695 | 2.28 | 0.52 | 1.36 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.82 | 2.4 | 2.46 | 3.17 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.592 | 0.506 | 0.446 | 0.372 |
Other Long Term Assets | ||||
Total Assets | 1.41 | 2.9 | 4.49 | 3.58 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 2.07 | 2.56 | 1.12 | 2.72 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 2.19 | 2.34 | 0.751 | 4.63 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.776 | 0.563 | 3.74 | -1.05 |
Total Liabilities & Shareholders' Equity | 1.41 | 2.9 | 4.49 | 3.58 |
Total Common Shares Outstanding |